NAT10 and E2F1 Orchestrate CKAP5-Mediated Progression in Esophageal Squamous Cell Carcinoma.

Key Points

• The research aims to identify and understand the roles of NAT10 and E2F1 in ESCC progression through the CKAP5 pathway.
• Mechanistic analysis of NAT10/CKAP5 and E2F1/CKAP5 interactions.
• Experimental validation of pathway involvement in cell models of ESCC.
• Assessment of potential therapeutic targets through inhibition of identified pathways.
• NAT10 and E2F1 were found to significantly promote CKAP5-mediated progression of ESCC.
• Targeting these pathways may offer new therapeutic strategies against esophageal squamous cell carcinoma.